Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | RAD52 | P43351 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6863719 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6910278 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6863386 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6872139 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6871081 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6870485 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6871073 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL6871618 | 0.98 | NAAA (0.52) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL19023368 | 0.95 | NAAA (0.56) | NAAANPSR1MAPTMAPK1L3MBTL1 | |
| SCHEMBL11047929 | 0.95 | NAAA (0.56) | NAAANPSR1MAPTMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103145553-B | Synthesis and application of 2, 3-alkyl substituted diester succinate | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2016-06-01 | — | — | CN | disclosed |
| CN-103145553-A | Synthesis and application of 2, 3-alkyl substituted diester succinate | UNIV DALIAN TECH | 2013-06-12 | — | — | CN | disclosed |
| EP-1165633-B1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE SPA (IT) | 2004-07-14 | — | — | EP | disclosed |
| US-6716939-B2 | COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2004-04-06 | — | — | US | disclosed |
| US-20020183575-A1 | Components and catalysts for the polymerization of olefins | BASELL POLIOLEFINE ITALIA S.P.A. (IT) | 2002-12-05 | — | — | US | disclosed |
| EP-1165633-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | Basell Technology Company B.V. (NL) | 2002-01-02 | — | — | EP | disclosed |
| WO-2001057099-A1 | COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS | BASELL TECHNOLOGY COMPANY B.V. (NL) | 2001-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183575-A1 | Components and catalysts for the polymerization of olefins | SCO2, ECI1, MT-CO2 | NAAA 4712/4885NPSR1 3979/4885MAPT 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.